Independence
We do not operate as a treatment provider. Our independent status helps us focus on clarity and risk context rather than promoting services.
About
Qadence is an independent resource on ibogaine screening risks and eligibility. Our mission is straightforward: to help people understand medical, psychiatric, medication-related, and practical factors that can affect ibogaine eligibility. We prioritize clear context on cardiac risk, monitoring limitations, and investigational status.
Evidence‑first
Editorial stance
Independent
Not a clinic
Plain language
Audience focus
Our editorial approach
We compile and summarize information from primary registries, peer-reviewed literature, and official guidance to create accessible summaries. Where possible we link to original sources and regulatory guidance so readers can verify claims themselves; for example, registry-level data and protocol summaries inform our process descriptions and are consulted when we discuss monitoring limitations.
For transparency about investigational status and regional service landscapes, our editorial notes include links to public-facing resources and listings; readers sometimes follow those listings to find more operational detail from service providers in different countries.
- Safety first — prioritize risk context and monitoring limits
- Plain language — translate clinical concepts without oversimplifying
- Evidence awareness — cite registries and peer-reviewed work where available
- Transparency — disclose uncertainty and limits of available data
How information is sourced and vetted
Our editorial workflow combines systematic searches of literature, consultation of clinical trial registries, and examination of publicly posted protocol summaries. We favor primary sources (published studies and registry entries) and link to authoritative sites when describing methodology and safety considerations; for example, general practices around clinical safety monitoring are summarized with reference to trustworthy resources such as the U.S. National Library of Medicine (nlm.nih.gov), and broader pharmacology context is sometimes clarified with established tertiary resources like the Clinical trial overview on Wikipedia.
We do not provide medical advice. Our pages are intended to inform questions you might bring to a licensed clinician.
Qadence is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice.
Editorial principles in practice
Clarity & sources
When summarizing evidence we cite registries, journal articles, and official guidance so readers can verify details themselves; our approach emphasizes traceability to the source material.
Independent by design
We aim to be a starting point for questions and to make the evidence easy to find. For operational details about providers and regional listings we sometimes reference public directories and informational sites; readers researching service availability may consult provider listings such as a documentary resource for community context (ibogainedocumentary.com) or directory-style aggregators offering regional overviews (Mexico ibogaine centers listing).
Where we look for context
When contextualizing treatment landscapes we may refer readers to European-focused overviews for comparative policy and access information, for example an aggregator that catalogs centers across the continent (ibogaine treatment centers in Europe).
For discussion of biochemical and potential benefit summaries we sometimes link to explanatory resources that synthesize observational findings (ibogaine benefits summaries) and to specialist sites that track product and protocol developments (ibogainestock information).
Readers curious about research framing and brain-focused investigations may find academic overviews and dedicated projects helpful; for example, a brain-aging research initiative provides a different lens on neurobiological questions (ibogaine brain aging project).